Shuangnian Xu

1.2k total citations
47 papers, 749 citations indexed

About

Shuangnian Xu is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Shuangnian Xu has authored 47 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 21 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Shuangnian Xu's work include Acute Myeloid Leukemia Research (20 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Multiple Myeloma Research and Treatments (7 papers). Shuangnian Xu is often cited by papers focused on Acute Myeloid Leukemia Research (20 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Multiple Myeloma Research and Treatments (7 papers). Shuangnian Xu collaborates with scholars based in China, United States and Hong Kong. Shuangnian Xu's co-authors include Xi Li, Jieping Chen, Yiping Wang, Guixian Wu, Chengxin Luo, Zhen Huang, Cheuk Him Man, Yongxiu Huang, Qiang Gong and Yu Hou and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Shuangnian Xu

43 papers receiving 734 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuangnian Xu China 17 354 185 131 118 106 47 749
Feiyu Zhang China 15 376 1.1× 221 1.2× 170 1.3× 92 0.8× 103 1.0× 61 1.0k
Mark Hong Lee South Korea 13 383 1.1× 197 1.1× 245 1.9× 176 1.5× 84 0.8× 63 904
Yixiang Han China 17 371 1.0× 250 1.4× 226 1.7× 100 0.8× 350 3.3× 32 923
Yi Kong China 16 415 1.2× 235 1.3× 82 0.6× 124 1.1× 71 0.7× 31 918
Kuan-Lin Kuo Taiwan 17 401 1.1× 80 0.4× 212 1.6× 95 0.8× 103 1.0× 28 758
Prosenjit Sen India 18 393 1.1× 249 1.3× 66 0.5× 149 1.3× 140 1.3× 48 953
Yuying Li China 11 171 0.5× 57 0.3× 78 0.6× 71 0.6× 87 0.8× 43 541
Céline Van Themsche Canada 18 544 1.5× 37 0.2× 246 1.9× 228 1.9× 118 1.1× 25 894
Takuro Nishikawa Japan 11 221 0.6× 118 0.6× 240 1.8× 106 0.9× 53 0.5× 60 677
Apriliana E. R. Kartikasari Australia 15 251 0.7× 231 1.2× 180 1.4× 69 0.6× 178 1.7× 25 789

Countries citing papers authored by Shuangnian Xu

Since Specialization
Citations

This map shows the geographic impact of Shuangnian Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuangnian Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuangnian Xu more than expected).

Fields of papers citing papers by Shuangnian Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuangnian Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuangnian Xu. The network helps show where Shuangnian Xu may publish in the future.

Co-authorship network of co-authors of Shuangnian Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuangnian Xu. A scholar is included among the top collaborators of Shuangnian Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuangnian Xu. Shuangnian Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Yu, Jianming Wang, Ruiying Zhao, et al.. (2025). Ciclosporin A potentiates venetoclax efficacy in FLT3‐ITD AML by targeting the NFATC1–AKT–mTOR–BCL‐2/MCL‐1 signaling axis. British Journal of Haematology. 207(1). 46–58. 1 indexed citations
2.
Yao, Qi, Ya Tan, Rui Bian, et al.. (2025). Pregnane X Receptor Activation Induces Ferroptosis Resistance Through Upregulation of FSP1. Molecular Carcinogenesis. 64(10). 1620–1637.
3.
Zhang, Xian, Yawen Liu, Shuangnian Xu, & Dongdong Zhang. (2025). Arsenic compounds in cancer therapy: mechanistic insights and antitumor activity. Biochemical Pharmacology. 240. 117093–117093.
4.
Yao, Xintong, et al.. (2024). Ticlopidine protects hepatic ischemia-reperfusion injury via suppressing ferroptosis. Biochemical and Biophysical Research Communications. 733. 150436–150436. 6 indexed citations
5.
6.
An, Lin, et al.. (2024). The novel HLA‐C*03:652 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA. 103(5). e15464–e15464. 1 indexed citations
7.
Luo, Chengxin, Guixian Wu, Zhen Huang, et al.. (2023). Effects of donor-specific antibodies on engraftment and long-term survival after allogeneic hematopoietic stem cell transplantation—A systematic review and meta-analysis. Bone Marrow Transplantation. 58(5). 544–551. 6 indexed citations
8.
Li, Junnan, Pei Li, Simin Liang, et al.. (2023). Gene mutation analysis using next‐generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi‐center study from China. Cancer Medicine. 12(8). 9332–9350. 5 indexed citations
9.
Jiang, Xiuxing, Guoxun Zheng, Zhiqiang Li, et al.. (2022). Targeting PI4KA sensitizes refractory leukemia to chemotherapy by modulating the ERK/AMPK/OXPHOS axis. Theranostics. 12(16). 6972–6988. 7 indexed citations
10.
11.
Chen, Zhe, Dawei Huo, Lei Li, et al.. (2021). Nuclear DEK preserves hematopoietic stem cells potential via NCoR1/HDAC3-Akt1/2-mTOR axis. The Journal of Experimental Medicine. 218(5). 31 indexed citations
12.
Luo, Chengxin, Guixian Wu, Yanni Ma, et al.. (2021). Efficacy and safety of new anti-CD20 monoclonal antibodies versus rituximab for induction therapy of CD20+ B-cell non-Hodgkin lymphomas: a systematic review and meta-analysis. Scientific Reports. 11(1). 3255–3255. 40 indexed citations
13.
Jiang, Xiuxing, Zhiqiang Li, Xin Ding, et al.. (2021). Decoding the Mechanism of Shen Qi Sha Bai Decoction in Treating Acute Myeloid Leukemia Based on Network Pharmacology and Molecular Docking. Frontiers in Cell and Developmental Biology. 9. 796757–796757. 13 indexed citations
14.
Li, Teng, Chengxin Luo, Jiasi Zhang, et al.. (2021). Efficacy and safety of mesenchymal stem cells co-infusion in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis. Stem Cell Research & Therapy. 12(1). 246–246. 32 indexed citations
15.
Li, Xi, et al.. (2018). Technical Advances in Single-Cell RNA Sequencing and Applications in Normal and Malignant Hematopoiesis. Frontiers in Oncology. 8. 582–582. 20 indexed citations
16.
Dong, Song, et al.. (2017). Genetic polymorphisms of NAT2 and risk of acute myeloid leukemia. Medicine. 96(42). e7499–e7499. 10 indexed citations
17.
Xu, Shuangnian, et al.. (2016). SIRT2 activates G6PD to enhance NADPH production and promote leukaemia cell proliferation. Scientific Reports. 6(1). 32734–32734. 93 indexed citations
18.
Xu, Shuangnian, Xi Li, Jianmin Zhang, & Jieping Chen. (2015). Prognostic Value of CD11b Expression Level for Acute Myeloid Leukemia Patients: A Meta-Analysis. PLoS ONE. 10(8). e0135981–e0135981. 12 indexed citations
19.
20.
Chen, Jieping, et al.. (2010). Blastic Plasmacytoid Dendritic Cell Neoplasm. Journal of Clinical Oncology. 29(2). e27–e29. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feiyu Zhang Breakdown of academic impact, for papers by Mark Hong Lee Breakdown of academic impact, for papers by Yixiang Han Breakdown of academic impact, for papers by Yi Kong Breakdown of academic impact, for papers by Kuan-Lin Kuo Breakdown of academic impact, for papers by Prosenjit Sen Breakdown of academic impact, for papers by Yuying Li Breakdown of academic impact, for papers by Céline Van Themsche Breakdown of academic impact, for papers by Takuro Nishikawa Breakdown of academic impact, for papers by Apriliana E. R. Kartikasari
Rankless by CCL
2026